Clinical Trial Update: Impact of Local Steroid Application in Extreme Lateral Lumbar Interbody Fusion [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating local steroid application in extreme lateral lumbar interbody fusion was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Herniated Nucleus Pulposus
• Myelopathy
• Myeloradiculopathy
• Radiculopathy
• Spondylosis
• Stenosis

Snippet

Sponsor: Rush University Medical Center | Conditions: Stenosis, Herniated Nucleus Pulposus | Phase 3 | Status: WITHDRAWN